Today’s top gainers include the company Grifols, S.A. (NASDAQ:GRFS) which is in the industry Biotechnology, gaining 0.82% today. In the last week its performance is 6.85%, and 8.14% for the past quarter. Currently, Grifols, S.A., GRFS has a target price of 15, so today’s gain of 0.82% is a significant step towards its target price. The GAP today is therefore 0.42%.
Grifols, S.A. (NASDAQ:GRFS), has a market cap of 22659.8, and is based in Spain. Insider ownership is at *TBA, and institutional ownership is *TBA.
At the current price of 16.67, it has a dividend yield of 3.14%, and its target price is 15. This is with a profit margin of *TBA, and total debt/equity of *TBA. Grifols, S.A. (NASDAQ:GRFS) has a P/E of 38.47, as well as a forward P/E of 14.51.
With a current EPS of 0.43, and a forecasted EPS growth for next year at 10.70%,Grifols, S.A. (NASDAQ:GRFS) has had a EPS growth for the past five years at 39.67%. For the next five years EPS growth is projected to be 15.00%.
Performance for the year is 9.66%. Since its IPO date on 06/02/2011, the total performance to date is 3.06%.
Volume today for Grifols, S.A. (NASDAQ:GRFS), is 152340, while its average volume is 1424.09. Whilst the total gain today was 0.82%, it did have a day high of -4.17%.
Volatility for this week has been at 1.92%, and 2.00% for the month. The 52-week low for Grifols, S.A., GRFS has been 19.64%, while the 52-week-high has reached -5.65%.
Looking at its return of investments, which is *TBA, and its return on assets is *TBA. Grifols, S.A. (NASDAQ:GRFS) has an operating margin of *TBA. With a sales growth of 5.60% quarter over quarter. Bearing in mind that Grifols, S.A., GRFS is in the sector Healthcare, its long-term debt/equity is *TBA, and has a current ratio of *TBA and *TBA for quick ratio.
So what is the value of Grifols, S.A.? Well its PEG is 2.56, and the P/S is 5.16, along with a P/B of 6.24. Meanwhile it has a p/cash of *TBA.